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Abstract
Background: The aim of the study was to evaluate the safety and efficacy of a novel metal-free ceramic total knee
replacement system.
Methods: Thirty-eight primary total knee arthroplasties (TKAs) were performed on 34 patients using the metal-free
BPK-S ceramic total knee replacement system with both the femoral and tibial components of an alumina/zirconia
ceramic composite. The clinical outcome was evaluated pre- and postoperatively at 3 (n = 32 TKA) and 12 months
(n = 32 TKA) using the Knee Society Score (KSS), the Oxford Knee Score and the EQ-5D. Safety analysis was
performed by radiological examination and assessment of adverse events.
Results: Postoperatively, the KSS, Oxford Knee Score and EQ-5D improved significantly at 3 and 12 months (p < 0.001).
Non-progressive partial radiolucent lines were observed in six cases, but there was no osteolysis and no implant
loosening. Induction or exacerbation of allergies did not occur during the follow-up.
Conclusions: The metal-free BPK-S ceramic total knee replacement system proved to be a safe and clinically efficient
alternative to metal implants in this short-term follow-up study.
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Background
One major factor limiting the implant survival in total
knee arthroplasty (TKA) is aseptic loosening due to im-
mune reactions resulting from the agglomeration of deb-
ris as a result of wear [1–3]. In order to reduce the
amount of implant wear, bearing couples of different
materials have been investigated for decades. Due to
favourable tribological properties, a significant reduction
in wear rates of ceramic bearings has been well demon-
strated in vitro and in vivo [4–6]. Furthermore, the
release of wear particles may also elicit allergenic reac-
tions, which are observed with metal implants [7]. Indeed,
the prevalence of metal hypersensitivity is approximately
10–15 %, with nickel sensitivity having the highest
prevalence in the presence of a common cross-
reactivity between nickel and cobalt [8]. Elevated cobalt
and chromium serum ion levels were reported in patients
after implantation of hip replacement devices [9]. Im-
munological metallic-specific responses to metal ions and
metal debris are considered possible causes for postopera-
tive pain, poor performance, osteolysis and early implant
loosening [10, 11].
These data underline the rationale for an implant that
is completely free from metal components. However, the
brittleness and low tensile strength with the risk of ma-
terial fractures are considerable problems for the use of
ceramics in joint replacement. This is particularly true
for the complex shape of TKA components. Indeed, ma-
terial fractures of ceramic TKA components have been
documented in some studies [12–14]. Majima et al. de-
scribed the need for revision surgery in one of 110 cases
because of breakage of the ceramic tibial tray [13].
Bergschmidt et al. observed four fractures of the ceramic
femoral condyle at the time of the implantation proced-
ure at the beginning of their study [12]. In another case
report, a fracture of the patellar groove of the ceramic
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Fig. 1 BPK-S Integration total knee replacement system with femoral
and tibial component of Biolox® ceramic composite (Peter Brehm,
Germany)
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was ascribed to a traumatic event [14].
For this reason, the use of ceramic has been confined
to the femoral TKA component so far. However, the de-
velopment of novel ceramic composites with improved
tensile strength and fracture toughness have also made it
possible to use ceramic for the tibial component. The
improved mechanical properties of the Biolox®delta cer-
amic composite were yielded by an alumina matrix
containing uniformly distributed particles of tetragonal
zirconium oxide.
The aim of this prospective, non-controlled single-
arm, open-label, observational study was to investigate
the efficacy and safety of the complete metal-free BPK-S
Integration ceramic knee replacement system.
Methods
Study population
A total of 34 patients were enrolled in this study. This
population included 38 TKAs (n = 38 TKA) with 21
(55.2 %) TKA in female and 17 (44.7 %) TKA in male pa-
tients. Surgery was performed on 17 (44.7 %) left and 21
(55.2 %) right knees. The mean age of the study population
at inclusion was 66.87 ± 9.76 (46–83) years. The median
height and weight of the patients were 172.5 (152.0–190.0)
cm and 92.5 (61.0–156.0) kg, respectively. The average
BMI of the patients was 31.4 ± 5.6 (22.7–47.8) kg/m2.
This study was performed as a prospective, non-
controlled single-arm, open-label, observational study
for the clinical and radiological evaluation of the metal-
free BPK-S Integration total knee replacement system
with femoral and tibial components of Biolox®delta
ceramic composite and an ultra-high-molecular-weight
polyethylene (UHMWPE) insert. The study was classi-
fied as evidence-based medicine (EBM) level 4. Inclusion
criteria were the indications of primary TKA due to
primary or posttraumatic osteoarthritis or rheumatoid
arthritis, congenital or acquired knee joint defect or de-
formation, and a known history of metal hypersensitivity.
Contraindications were severe damage to bone struc-
tures which could impede the stable fixation of the im-
plant components, infection near the implantation site,
cancer and renal dialysis. Patients with drug abuse, men-
tal diseases or lack of cooperation were excluded from
the study. The study was approved by the institutional
ethics committee of the medical faculty of the University
Erlangen-Nuremberg, and all patients gave their written,
informed consent.
Total knee replacement system
The BPK-S Integration is a non-constrained primary
total knee replacement device (Peter Brehm GmbH,
Weisendorf, Germany) with both the bicondylar femoral
element and the tibial component of alumina/zirconiaceramic composite (Biolox®delta; CeramTec AG, Plochingen,
Germany) (Fig. 1). The rotating or fixed-bearing insert is
made of UHMWPE. The device can be combined with a
patella replacement made of UHMWPE. The geometrical
design of the ceramic BPK-S Integration is identical to the
clinically established cobalt-chromium BPK-S Integration
by the same manufacturer. The mechanical and clinical ef-
ficacy and safety of the conventional cobalt-chromium
BPK-S TKA has been proven in recent studies [15, 16].
Prior to this clinical study, the metal-free ceramic
BPK-S tibia component underwent extensive mechanical
tests under experimental conditions, which were per-
formed according to the standards ISO 14879-1:2000(E)
and ASTM F1800-07. All of the tested BPK-S ceramic
tibia components (size “3” n = 7; size “6” n = 2) withstood
the alternating load test with ten million cycles of sinus-
oidal dynamic stress (10 Hz) with 5300 N topload and
530 N underload. The subsequent post-fatigue burst
strength test revealed the maximum strength against
fracture of the same specimen. The burst strength until
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ponents or 13.6 ± 2.0 kN for size “6” tibial components,
respectively. These experiments demonstrated large re-
serves in the mechanical strength of the ceramic tibia
components, which exceeded by far the required safety
norms (DIN EN ISO 21536:2009).
Intra- and perioperative management
Long-leg standing radiographs were the basis for pre-
operative planning using a digital surgical planning soft-
ware (MediCAD, HECTEC GmbH, Landshut, Germany).
The alignment was adjusted to the mechanical axis with
the femoral and tibial resection lines perpendicular to the
mechanical axis of the femur and tibia according to Insall
et al. [17]. The pre-defined implant slope was 6°. The cut-
ting levels were defined by the digital planning software.
All TKAs were implanted by conventional surgical
methods using the standard instruments from the manu-
facturer intended for implantation of the established
cobalt-chromium BPK-S with the exception of a single-
use plastic-coated peg of the applicator for the femoral
component and a modified applicator for the tibial com-
ponent. These modified applicators prevented the metal
instruments from having any contact with the ceramic
components. The femoral and tibial ceramic components
were fixed to the bone in a one-stage technique with
polymethyl-methacrylate (PMMA) bone cement (Stryker
Simplex; Duisburg, Germany). The postoperative mobiliza-
tion was performed according to the current standards.
On the first day after surgery, the patients began exercising
their knee joint in an unlimited range of motion under the
supervision of a physiotherapist and use of a continuous
passive motion (CPM) device. They were allowed a partial
weight-bearing of 20 kg for the first 2 weeks followed by
the transition to full weight-bearing after wound healing.
Radiological evaluation
The radiological evaluation was performed by standard
anterior-posterior and lateral X-ray imaging preopera-
tively, directly postoperatively (day of surgery), as well as
3 and 12 months after surgery. Long-leg standing radio-
graphs were done preoperatively and postoperatively at
the time of discharge. The images were evaluated for tib-
ial and femoral implant positioning and alignment, peri-
prosthetic fractures, radiolucent lines and osteolysis by
three independent observers according to the Knee Soci-
ety roentgenographic evaluation [18].
Clinical evaluation
The efficacy of the TKA procedure was performed pre-
operatively (baseline), as well as at 3 and at 12 months
postoperatively using the Knee Society Score (KSS), the
Oxford Knee Score and the EQ-5D plus VAS. Safety var-
iables included early and late TKA revisions, radiologicalsigns of functional or structural alterations (loosening,
wear, dislocation, deformation and damage), medical de-
vice incidents, and intra-/peri-/or postoperative compli-
cations throughout the entire study period.
Statistical analysis
All data were analysed using the SPSS statistical package
(SPSS Inc., Chicago, USA). The data of KSS, Oxford Score
and EQ-5D are presented as mean ± SD (95 % CI) or by
boxplot analysis showing minimum, 25 % quartile; me-
dian, 75 % quartile; and maximum values. The efficacy of
the procedure with comparison of the outcome at the dif-
ferent time points was evaluated using the two-sided
Wilcoxon sign-rank test. p values lower than 0.05 were
considered significant.
Results
A total of 34 patients were enrolled in the study (n = 38
TKA). Out of these, 28 patients (n = 32 TKA) completed
the 3- and 12-month follow-up examination. Among the
drop-outs during the study, five patients withdrew their
consent for personal reasons, and one patient dropped
out due to poor health status (stroke). There was no case
of discontinuation related to the TKA device.
Mean duration surgery time (n = 38) was 70.21 (SD ±
9.97) minutes. The size of the implants ranged from “4”
to “6” for the femoral component, “4” to ”6” for the tibial
component and “7” to “13” for the insert (Figs. 2 and 3).
Patella replacement was not carried out on any patient
in this study. There were no technical problems during
the implantation. Intraoperative implant failure or prob-
lems related to the cement fixation of the ceramic com-
ponents did not occur in any of the patients.
Postoperative radiographs demonstrated a mean anatom-
ical femoro-tibial valgus of 6.18° ± 1.5° (range 4°–9°). The
mean mechanical lateral distal femoral angle (mLDFA) was
89.7° ± 1.5° (range 87°–92°), which adequately corresponds
to the preoperative planning (aberrance <3° in all cases).
Efficacy outcome
The KSS (total score, subscore knee, subscore function),
Oxford Knee Score and EQ-5D plus VAS improved sig-
nificantly (p < 0.05) from the preoperative evaluation to
the postoperative evaluations at 3 and 12 months. The
“total” KSS score increased from a mean of 92.45 (SD
30.59, n = 38) at baseline (preoperative evaluation) to a
mean of 174.22 (SD 15.61, n = 32) at 3-month follow-up
and to a mean of 189.13 (SD 15.61, n = 32) at 12-month
follow-up. The change from baseline was statistically sig-
nificant (p < 0.0001) for both points in time (Fig. 4). The
KSS “knee score” improved from a mean of 38.84 (SD
15.75, n = 38) at baseline (preoperative evaluation) to a
mean of 88.44 (SD 9.09, n = 32) at 3-month follow-up
and to a mean of 93.66 (SD 7.41, n = 32) at 12-month
Fig. 2 Size specifications of the femoral component of the BPK-S Integration total knee replacement system
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nificant (p < 0.0001) for both points in time (Fig. 4). The
KSS “functional score” increased from a mean of 53.61
(SD 18.45, n = 38) at baseline (preoperative evaluation) to
a mean of 85.78 (SD 9.51, n = 32) at 3-month follow-upFig. 3 Size specifications of the tibial component of the BPK-S Integrationand to a mean of 95.47 (SD 12.01, n = 32) at 12-month
follow-up. The change from baseline was statistically sig-
nificant (p < 0.0001) for both points in time (Fig. 4).
The Oxford Knee Score decreased (clinically improved)

























Fig. 4 Boxplot analysis of the KSS score values (functional score and
knee score preoperatively as well as at 3 and 12 months postoperatively
(**p < 0.01 vs. preoperative)
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32) at 3-month follow-up and 20.63 (SD 3.85, n = 32) at
12-month follow-up (Fig. 5). The change from baseline
was significant (p < 0.0001) for both points in time.
The EQ-5D increased from a mean of 46.24 (SD 14.13,











Oxford Knee Score 
Fig. 5 Boxplot analysis of the Oxford Knee Score preoperatively as well
as at 3 and 12 months postoperatively (**p < 0.01 vs. preoperative)85.25 (SD 8.33, n = 32) at 3-month follow-up and 89.66
(SD 10.69, n = 32) at 12-month follow-up (Fig. 6). The
change from baseline was significant (p < 0.0001) for all
the points in time. The VAS improved from a mean of
33.24 (SD 14.88, n = 38) at baseline (preoperative evalu-
ation) to a mean of 77.66 (SD 8.42, n = 32) at 3-month
follow-up and 82.19 (SD 12.11, n = 32) at 12-month
follow-up (Fig. 6). The change from baseline was signifi-
cant (p < 0.0001) for both points in time.
Safety outcome
There were no failures of the implant during surgery or
the reported follow-up period. There was no case of intra-
operative nor postoperative periprosthetic bone fractures.
Non-progressive radiolucent lines were seen in one fem-
oral component (zone 1) and five tibial components (n = 2
in zone 1 (lateral view); n = 1 in zone 1 (a.p. view); n = 1 in
zone 1 + 2 (a.p. view); n = 1 in zone 3 + 4 (a.p. view)). All
radiolucent lines were measured less than 1 mm in width
and were observed between the bone and cement. All
radiolucent lines were observed at the 3-month follow-up
and showed no further progression at the 12-month
follow-up. There was no loosening of the TKA device in
any of the patients. The positioning of the implants
remained correct throughout the follow-up period (Fig. 7).
There were a total of three complications that all oc-
curred during the follow-up period. In one patient, a sur-
gical superficial wound revision (without revision of the
implant) was necessary, which subsequently healed with-
out any further complications. One patient had an out-of-
hospital stroke with a persisting hemiparesis 1 month after
TKA implantation. A causality of the stroke event with
the implanted TKA was not apparent. One patient devel-
oped a deep vein thrombosis 3 months after TKA
implantation. The thrombosis was resolved without re-













Fig. 6 Boxplot analysis of the EQ-5D score values preoperatively as
well as at 3 and 12 months postoperatively (**p < 0.01 vs. preoperative)
Fig. 7 Radiographs of one patient preoperatively (a), postoperatively (day of surgery) (b), 3 months (c) and 12 months (d) after surgery
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This is the first study investigating the clinical outcome
and safety of a completely metal-free total knee replace-
ment system with both femoral and tibial components
made out of ceramic material. The complex biomechan-
ical loads with considerable bending and torsional forces
have challenged the use of ceramic for the tibia compo-
nent and have limited the use of ceramic for the femoral
component so far [12, 19]. The development of a novel
alumina/zirconia ceramic composite has made it also
possible to build the tibial component out of ceramic.
In the limited follow-up of 12 months of this study, we
could not detect any device-related complications. There
was no implant breakage or aseptic loosening in any of
the patients of this present study. These encouraging
results concerning implant safety may be a result of the
unique Biolox®delta ceramic material, which is a compos-
ite matrix material containing aluminium oxide (AL2O3)
and zirconium oxide (ZrO2) with improved mechanical
characteristics in terms of strength and resistance [20].
Furthermore, careful intraoperative handling was per-
formed with strict avoidance of any contact of the ceramic
components by metal instruments. For this purpose,
unique applicator devices with single-use plastic-coated
pegs were developed.
Radiological examination revealed radiolucent lines
around one femoral component and five tibial compo-
nents, which were all observed between the bone and
cement. The frequency of radiolucent lines is compar-
able to those in other studies using metal TKA devices
and may be ascribed to stress-shielding phenomena or
poor cement penetration due to sclerotic bone [21]. The
radiolucent lines were not progressive, and there was no
aseptic loosening of the ceramic TKA components in
this study. Due to the lack of any loosening event of a
ceramic component, TKA survival rates were not calcu-
lated in the present study but will be addressed in the
ongoing course of study.
Finally, none of the patients developed an allergic reac-
tion to the implant or exacerbation of existing hypersen-
sitivities. This underlines the rationale of a completemetal-free TKA for the use in patients with known
hypersensitivities.
The analysis of the efficacy demonstrated that all pa-
tients significantly gained benefit from the implantation
of the ceramic TKA by improved or restored knee func-
tion, mobility, quality of life and pain situation. In the
present study, the KSS increased from 38.84 (knee score)
or 53.61 (function score) at baseline to 93.7 or 95.5 at
the 12-month follow-up, respectively. Thus, the func-
tional outcome of the ceramic BPK-S Integration is
comparable to established TKA devices. Recently, two
large studies reported postoperative KSS (function score)
values between 76.9 and 94.2 at the 12-month follow-up
with the standard NexGen knee (Zimmer) or its high-
flexion version [22, 23]. One study compared the clinical
outcome of the AGC V2, Duracon and NexGen TKA
devices and revealed KSS (knee score) values of 90.0,
79.9 and 86.0 and KSS (function score) values of 97.7,
90.5 and 96.2, respectively [24].
Thus, with respect to the clinical performance, the
BPK-S ceramic TKA device meets the functional per-
formance of established primary standard metal TKA
systems that are currently in clinical use. Furthermore,
the implantation of the BPK-S ceramic implant does not
require any differential inclusion nor exclusion criteria.
For the surgeon, the switchover to the ceramic TKA sys-
tem appears to be completely unproblematic, since the
surgical technique and target alignment are comparable
to the current metal component system.
Some limitations of this study have to be considered
when interpreting the data. First, it was a non-randomized
single-arm study. Follow-up evaluations were limited to 3
and 12 months postoperatively so far and, thus, do not
allow the evaluation of, e.g. polyethylene wear. Neverthe-
less, this pilot study could exclude severe complications
related to the ceramic TKA device that may predomin-
antly occur during surgery or within the first postoperative
months. Revision analyses of TKA surgery demonstrated
that about 19 % all revisions had to be done in less than
12 months after the primary procedure [25]. However,
longer follow-up periods will be required to draw final
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wear of the ceramic TKA and may be able to reveal the
potential advantages of the ceramic TKS systems.
Conclusions
This is the first clinical study on a completely metal-free
TKA device with both the femoral and tibial component
made out of Biolox®delta ceramic. The ceramic BPK-S
Integration proved to be safe with no implant failure nor
loosening in the limited follow-up period of 12 months.
Thus, the ceramic implant may represent a promising
alternative in particular for patients with a known hyper-
sensitivity to metal. Long-term studies will have to ap-
prove the favourable short-term clinical outcome as well
as implant survival rates.
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